Washington, DC – June 8, 2021 – Friends of Cancer Research (Friends) is proud to announce the launch of Step 2 of the ctDNA for Monitoring Treatment Response (ctMoniTR) Project. This project aims to determine the extent to which changes in circulating tumor DNA (ctDNA) are an early indicator of response to therapy on a larger…
Washington, DC – April 12, 2021 – Friends of Cancer Research would like to congratulate Dr. Patrizia Cavazzoni for being named the director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA). “The naming of Dr. Cavazzoni as director of CDER at FDA by Acting Commissioner Woodcock…
Washington, DC – January 20, 2021 – Friends of Cancer Research (Friends) would like to applaud President Biden for selecting Dr. Janet Woodcock to serve as acting Commissioner of the U.S. Food and Drug Administration (FDA). We look forward to working with Dr. Woodcock in her new role as the acting lead at the FDA,…
Bipartisan MODERN Labeling Act Included Washington, DC – December 22, 2020 – Friends of Cancer Research (Friends) applauds the bipartisan work of the House and Senate to bolster the U.S. economy and support patients, physicians, and families during the COVID-19 pandemic. We would also like to acknowledge the strong bipartisan work of the Members and…
Washington, DC – December 2, 2020 – Friends of Cancer Research (Friends) praises the scientific endeavor that has unfolded during the past months to discover a safe and effective vaccine against the novel coronavirus (COVID-19). It has been no small feat and could not have been achieved as quickly and safely as it has without…
Washington, DC – Today, the Reagan-Udall Foundation for the FDA, in collaboration with Friends of Cancer Research, announce the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder, collaborative project to leverage real-world data in the diagnostic test (e.g., nucleic acid or antigenic) and antibody test (e.g., serological) study space. Bringing together device manufacturers, technology companies, government and…
Today, Friends of Cancer Research (Friends) released the findings from Phase 2 of its TMB Harmonization Project at the AACR Virtual Annual Meeting I. These results are the outcome of the large-scale project led by Friends, which is leading the standardization of tumor mutational burden (TMB) calculation and reporting, in order to more effectively evaluate…
The Reagan-Udall Foundation for the FDA (Foundation) in collaboration with Friends of Cancer Research (Friends) today announced the COVID-19 Evidence Accelerator, an expansive public-private partnership combining the efforts of academic, government, and private sector organizations applying data analytics to accelerate the understanding of COVID-19. “We are honored to be launching this new initiative, working…
Like millions of our colleagues, friends, and family, Friends of Cancer Research is adjusting to the rapidly changing public health crisis being caused by COVID-19 (Novel Coronavirus). We are steadfast in our commitment to patients and will be working everyday to move our research, scientific programs, and policy solutions forward on their behalf. While…
Friends of Cancer Research (Friends) would like to thank Senators Burr and Bennet and Representatives DeGette and Bucshon for their commitment to patients through the introduction of the Verifying Accurate, Leading‑edge IVCT Development (VALID) Act. By continuing to advance this legislation, which would enable uniform oversight of diagnostics, these members have set a path toward…
